HIF-α signaling regulates the macrophage inflammatory response during Leishmania major infection

Insights

Host inflammation, not the parasite, triggers HIF-α signaling in macrophages during Leishmania infection. This signaling suppresses protein translation in a pro-inflammatory environment, highlighting new therapeutic targets for cutaneous leishmaniasis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Tropical Diseases

Background:

  • Cutaneous leishmaniasis (CL) is a neglected tropical disease affecting 12 million people globally.
  • Current treatments are often ineffective, and no vaccine exists, necessitating novel therapeutic targets.
  • Previous research linked macrophage HIF-α (hypoxia-inducible factor-alpha) to wound healing in Leishmania major infection via lymphangiogenesis.

Purpose of the Study:

  • To investigate the role of macrophage HIF-α signaling independently of lymphangiogenesis.
  • To determine whether the parasite or host inflammation drives myeloid HIF-α signaling in the lesional microenvironment.
  • To elucidate the transcriptomic and pathway alterations associated with HIF-α activation during Leishmania infection.

Main Methods:

  • RNA sequencing of macrophages from mice with intact or deleted HIF-α signaling.
  • Infection with Leishmania major parasites under both standard and pro-inflammatory conditions.
  • Pathway analysis of transcriptomic data to identify affected biological processes.

Main Results:

  • Leishmania major infection alone induced minor HIF-α-dependent transcriptomic changes.
  • Combined infection and pro-inflammatory stimuli resulted in significant HIF-α-dependent and independent transcriptomic alterations.
  • HIF-α was found to suppress protein translation pathways specifically within a pro-inflammatory context during infection.

Conclusions:

  • The host's inflammatory response, rather than the parasite itself, is the primary driver of myeloid HIF-α signaling during Leishmania infection.
  • HIF-α activation in macrophages plays a crucial role in modulating the host's response to infection, particularly in suppressing protein translation under inflammatory conditions.
  • These findings identify macrophage HIF-α signaling as a potential therapeutic target for managing cutaneous leishmaniasis.